The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

The Tennessee Board of Parole unanimously determined that the country star should be pardoned, but the decision is in the ...

The singer and flutist hopped on Instagram Live to break down how she lost weight and what she does to ensure she focuses on ...

The operation came as President Donald Trump is approaching 100 days into his second term, marked by a surge of controversial ...

This video highlights a drug trafficking ring that was involved in an FBI drug bust in Pittsburgh. 400 pounds of meth and 2 ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer is deeply undervalued, and has a high dividend yield, and I see tons of institutions and analysts buying the dip. Read ...

Following a meeting with the US FDA, clinical-stage biotech Dimerix has confirmed the appropriate primary endpoint for full ...

Report Ocean has published a new report on the Saudi Arabia Implantable Drug Delivery Devices market, delivering an extensive analysis of key factors such as market restraints, dr ...

One of the greatest innovations benefiting public health was regulation. In the pre-FDA "patent medicine" days, there were countless products on the market that ranged from useless to directly harmfu ...

An incompetent Ayrshire nurse whose repeated failings over more than a decade could have caused a patient's death has been struck off.

With this in mind, Cuban's recent prediction of tariffs trouble for Amazon especially grabbed my attention. Should Amazon investors (including yours truly) be concerned? Cuban doesn't seem to be a big ...